Capitalizing on transparency: Commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act
S Mulinari, P Ozieranski - Big Data & Society, 2022 - journals.sagepub.com
How corporations surveil and influence consumers using big data tools is a major area of
research and public debate. However, few studies explore it in relation to physicians in the …
research and public debate. However, few studies explore it in relation to physicians in the …
[HTML][HTML] Sustaining a new model of acute stroke care: a mixed-method process evaluation of the Melbourne mobile stroke unit
Background: Internationally, Mobile Stroke Unit (MSU) ambulances have changed pre-
hospital acute stroke care delivery. MSU clinical and cost-effectiveness studies are …
hospital acute stroke care delivery. MSU clinical and cost-effectiveness studies are …
Combatting corruption in the pharmaceutical sector
MA Gagnon - Integrity of scientific research: Fraud, misconduct and …, 2022 - Springer
The pharmaceutical sector is a complex and highly regulated sector in which minor technical
or regulatory decisions about products' safety, effectiveness, intellectual property or …
or regulatory decisions about products' safety, effectiveness, intellectual property or …
Public database on pharmaceutical ties in Japan: Traffic and user attitudes on industry-professional relationships
Background It is imperative to understand the specific details of the usage of the databases
documenting financial ties between pharmaceutical companies and the healthcare sector …
documenting financial ties between pharmaceutical companies and the healthcare sector …
Business as usual? How the pharmaceutical industry protected its long-term interests during and after eurozone bailouts (2011–2020)
D Teixeira Pereira, C Moury… - Political Research …, 2023 - Taylor & Francis
In this article, we start from the assumption that the pharmaceutical industry accumulates
material, instrumental, ideational and institutional power. Considering this, we expect that it …
material, instrumental, ideational and institutional power. Considering this, we expect that it …
Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic
Objectives During the coronavirus disease 2019 (COVID-19) pandemic, public debates
overtly addressed the promises of new innovative drugs. Many of these debates pitted those …
overtly addressed the promises of new innovative drugs. Many of these debates pitted those …
[HTML][HTML] Biopharmaceutical financialization and public funding of medical countermeasures (MCMs) in Canada during the COVID-19 pandemic
Background: Analysing the Canadian government's efforts to support the development of
COVID-19" medical countermeasures"(MCMs), this article seeks insights into political …
COVID-19" medical countermeasures"(MCMs), this article seeks insights into political …
Les essais cliniques, des instruments de recherche comme les autres? Étude d'un essai clinique de médecine de précision en France
D Boaventura Bomfim 1, É Schultz 2 - Zilsel, 2022 - cairn.info
En raison de leur centralité dans la production des savoirs médicaux, les essais cliniques
font l'objet de multiples attentions de la part des sciences sociales, allant des enjeux …
font l'objet de multiples attentions de la part des sciences sociales, allant des enjeux …
Canadian Policy Stakeholder Framings of the Overdose Crisis: Implications for Public Health, the Opioid Industry, and Framing Coalitions
DE Klein - 2024 - search.proquest.com
This dissertation sets out to analyze the ways that Canadian policy stakeholders frame
prescription opioids and the overdose crisis via a multi-case study of three distinct federal …
prescription opioids and the overdose crisis via a multi-case study of three distinct federal …
Mettre en place la médecine de précision au travers d'un essai clinique: le cas du projet pilote en cancérologie du plan France médecine génomique 2025
DB Bomfim - 2023 - theses.hal.science
Cette recherche doctorale en sociologie a eu pour objectif de suivre le déploiement du Plan
France Médecine Génomique 2025 (PFMG 2025) à partir de l'étude d'un de ses projets …
France Médecine Génomique 2025 (PFMG 2025) à partir de l'étude d'un de ses projets …